Levonorgestrel Releasing Intrauterine System (Mirena) Versus Endometrial Ablation (Novasure) in Women with Heavy Menstrual Bleeding: a Multicentre Randomised Controlled Trial

Background: Heavy menstrual bleeding is an important health problem. Two frequently used therapies are the levonorgestrel intra-uterine system (LNG-IUS) and endometrial ablation. The LNG-IUS can be applied easily by the general practitioner, which saves costs, but has considerable failure rates. As an alternative, endometrial ablation is also very effective, but this treatment has to be performed by a gynaecologist. Due to lack of direct comparison of LNG-IUS with endometrial ablation, there is no evidence based preferred advice for the use of one of these treatment possibilities.

Method/design: A multicenter randomised controlled trial, organised in a network infrastructure in the Netherlands in which general practitioners and gynaecologists collaborate.

Discusson: This study, considering both effectiveness and cost effectiveness of LNG-IUS versus endometrial ablation may well improve care for women with heavy menstrual bleeding.

Trial Registration: Dutch trial register, number NTR2984.

Citing Articles

First and second-generation endometrial ablation devices: A network meta-analysis.

Marchand G, Masoud A, Grover S, King A, Brazil G, Ulibarri H BMJ Open. 2024; 14(5):e065966.

PMID: 38806429 PMC: 11138282. DOI: 10.1136/bmjopen-2022-065966.

Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.

Bofill Rodriguez M, Dias S, Jordan V, Lethaby A, Lensen S, Wise M Cochrane Database Syst Rev. 2022; 5:CD013180.

PMID: 35638592 PMC: 9153244. DOI: 10.1002/14651858.CD013180.pub2.

The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.

van den Brink M, Beelen P, Herman M, Geomini P, Dekker J, Vermeulen K BJOG. 2021; 128(12):2003-2011.

PMID: 34245652 PMC: 8518490. DOI: 10.1111/1471-0528.16836.

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.

Beelen P, van den Brink M, Herman M, Geomini P, Duijnhoven R, Bongers M BMC Womens Health. 2021; 21(1):57.

PMID: 33563257 PMC: 7871623. DOI: 10.1186/s12905-021-01210-x.

Factors affecting patient recruitment to trials: qualitative research in general practice.

van den Brink M, Hummel M, Lemstra M, Berger M, Dekker J, Blanker M BJGP Open. 2020; 4(3).

PMID: 32723785 PMC: 7465591. DOI: 10.3399/bjgpopen20X101056.

References

Shapley M, Jordan K, Croft P . An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004; 54(502):359-63. PMC: 1266170. View

Abbott J, Garry R . The surgical management of menorrhagia. Hum Reprod Update. 2002; 8(1):68-78. DOI: 10.1093/humupd/8.1.68. View

Marjoribanks J, Lethaby A, Farquhar C . Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006; (2):CD003855. DOI: 10.1002/14651858.CD003855.pub2. View

Crosignani P, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O . Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol. 1997; 90(2):257-63. DOI: 10.1016/S0029-7844(97)00226-3. View

Shaw R, Symonds I, Tamizian O, Chaplain J, Mukhopadhyay S . Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol. 2007; 47(4):335-40. DOI: 10.1111/j.1479-828X.2007.00747.x. View

Soysal M, Soysal S, Ozer S . A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralbl Gynakol. 2002; 124(4):213-9. DOI: 10.1055/s-2002-32434. View

Istre O, Trolle B . Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril. 2001; 76(2):304-9. DOI: 10.1016/s0015-0282(01)01909-4. View

Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H . Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG. 2004; 111(10):1095-102. DOI: 10.1111/j.1471-0528.2004.00253.x. View

Irvine G, Lumsden M, Heikkila A, Walker J, Cameron I . Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol. 1998; 105(6):592-8. DOI: 10.1111/j.1471-0528.1998.tb10172.x. View

10.

Roberts T, Tsourapas A, Middleton L, Champaneria R, Daniels J, Cooper K . Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ. 2011; 342:d2202. PMC: 3082380. DOI: 10.1136/bmj.d2202. View

11.

Milsom I, Andersson K, Andersch B, RYBO G . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol. 1991; 164(3):879-83. DOI: 10.1016/s0002-9378(11)90533-x. View

12.

Shaw R . Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol. 1994; 101 Suppl 11:15-8. DOI: 10.1111/j.1471-0528.1994.tb13690.x. View

13.

Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J . Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013; 368(2):128-37. DOI: 10.1056/NEJMoa1204724. View

14.

Ewies A . Levonorgestrel-releasing intrauterine system--the discontinuing story. Gynecol Endocrinol. 2009; 25(10):668-73. DOI: 10.1080/09513590903159656. View

15.

Bongers M, Mol B . Thermal balloon ablation versus endometrial resection for treatment of abnormal uterine bleeding. Hum Reprod. 2000; 15(6):1424-5. DOI: 10.1093/humrep/15.6.1424-a. View

16.

Busfield R, Farquhar C, Sowter M, Lethaby A, Sprecher M, Yu Y . A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG. 2006; 113(3):257-63. DOI: 10.1111/j.1471-0528.2006.00863.x. View

17.

Nagele F, Rubinger T, Magos A . Why do women choose endometrial ablation rather than hysterectomy?. Fertil Steril. 1998; 69(6):1063-6. DOI: 10.1016/s0015-0282(98)00082-x. View

18.

Barrington J, Arunkalaivanan A, Abdel-Fattah M . Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol. 2003; 108(1):72-4. DOI: 10.1016/s0301-2115(02)00408-6. View

19.

Middleton L, Champaneria R, Daniels J, Hilken N, ODonovan P, Gray R . Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ. 2010; 341:c3929. PMC: 2922496. DOI: 10.1136/bmj.c3929. View

20.

Gallinat A, Nugent W . NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc. 2002; 9(3):283-9. DOI: 10.1016/s1074-3804(05)60405-7. View